ExpressPoints: Personalizing Therapy With Factor VIII Prophylaxis in Hemophilia A

Download this summary slideset with essential expert insights on the clinical management of patients with hemophilia A.
Michael Callaghan, MD
Miguel A. Escobar, MD
Guy A. Young, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 252 KB
Released: November 5, 2020


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from
Takeda Pharmaceuticals USA, LLC

Related Content

Commentary from Michael Callaghan, MD, on individualizing hemophilia prophylaxis with extended half-life products and PK profiling tools, from CCO

Michael Callaghan, MD Released: November 20, 2020

Janet L. Kwiatkowski, MD, MSCE, on current and emerging therapies for beta-thalassemia in a commentary from Clinical Care Options (CCO)

Janet L. Kwiatkowski, MD, MSCE Released: November 12, 2020

Downloadable slides with expert analysis on managing CVD and other comorbidities in older patients with hemophilia A, from Clinical Care Options.

Miguel A. Escobar, MD Released: October 29, 2020

Downloadable slides with expert analysis of treating patients with hemophilia A with EHL Factor VIII therapy from Clinical Care Options.

Guy A. Young, MD Released: October 29, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.